Published in Blood on May 06, 2010
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med (2013) 2.39
Dendritic cell control of tolerogenic responses. Immunol Rev (2011) 2.13
How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol (2010) 2.11
Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury. J Clin Invest (2012) 2.00
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol (2012) 1.70
CD4⁺T cells: differentiation and functions. Clin Dev Immunol (2012) 1.56
The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology. Front Immunol (2016) 1.45
Regulation of adaptive immunity; the role of interleukin-10. Front Immunol (2013) 1.38
Role of dendritic cells in the induction of regulatory T cells. Cell Biosci (2011) 1.27
Tolerogenic dendritic cells and their role in transplantation. Semin Immunol (2011) 1.26
Type 1 regulatory T cells (Tr1) in autoimmunity. Semin Immunol (2011) 1.24
Clinical perspectives for regulatory T cells in transplantation tolerance. Semin Immunol (2011) 1.23
The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells. Front Immunol (2012) 1.23
The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood (2012) 1.15
Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance. Cell Mol Immunol (2015) 1.11
Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci U S A (2014) 1.10
Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J Immunol (2012) 1.09
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation. Blood (2013) 1.07
HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy. Hum Immunol (2012) 1.06
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials. Front Immunol (2012) 1.03
Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol (2013) 1.02
Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells. Front Immunol (2014) 1.01
The ONE Study compares cell therapy products in organ transplantation: introduction to a review series on suppressive monocyte-derived cells. Transplant Res (2012) 1.01
Mesenchymal stem cell-educated macrophages. Transplant Res (2012) 1.00
Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. Eur J Immunol (2011) 1.00
Thymic versus induced regulatory T cells - who regulates the regulators? Front Immunol (2013) 0.98
Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells. Front Immunol (2011) 0.96
The dual role of HLA-G in cancer. J Immunol Res (2014) 0.94
Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res (2014) 0.94
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells. Mol Ther (2012) 0.93
Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proc Natl Acad Sci U S A (2012) 0.93
Lipopolysaccharide-activated dendritic cells: "exhausted" or alert and waiting? J Immunol (2012) 0.93
Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. Haematologica (2010) 0.93
CCAAT/enhancer binding protein-δ expression by dendritic cells regulates CNS autoimmune inflammatory disease. J Neurosci (2011) 0.93
Human tolerogenic DC-10: perspectives for clinical applications. Transplant Res (2012) 0.93
Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs. Transplant Res (2012) 0.92
Transcriptional and posttranscriptional regulations of the HLA-G gene. J Immunol Res (2014) 0.92
The nature of activatory and tolerogenic dendritic cell-derived signal II. Front Immunol (2013) 0.91
Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver? Cell Mol Immunol (2014) 0.90
The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection. J Immunol (2011) 0.90
Cell therapy using tolerogenic dendritic cells in transplantation. Transplant Res (2012) 0.89
The role of HLA-G in immunity and hematopoiesis. Cell Mol Life Sci (2010) 0.88
Targeting regulatory T cells to improve vaccine immunogenicity in early life. Front Microbiol (2014) 0.88
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man. Front Immunol (2015) 0.88
Synthetic HLA-G proteins for therapeutic use in transplantation. FASEB J (2013) 0.87
Dendritic cells a double-edge sword in autoimmune responses. Front Immunol (2012) 0.87
Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes. Diabetes (2012) 0.87
HLA-G Molecules in Autoimmune Diseases and Infections. Front Immunol (2014) 0.87
The battle against immunopathology: infectious tolerance mediated by regulatory T cells. Cell Mol Life Sci (2011) 0.87
Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy. Front Immunol (2015) 0.86
Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. Cell Mol Life Sci (2012) 0.85
Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells. Eur J Immunol (2010) 0.85
HLA-G as a tolerogenic molecule in transplantation and pregnancy. J Immunol Res (2014) 0.85
Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation. J Transplant (2013) 0.85
The Role of Dendritic Cell Subsets and Innate Immunity in the Pathogenesis of Type 1 Diabetes and Other Autoimmune Diseases. Front Immunol (2015) 0.85
Interactions between HLA-G and HLA-E in Physiological and Pathological Conditions. Front Immunol (2014) 0.84
Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction. Front Immunol (2014) 0.84
Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy. Front Microbiol (2011) 0.83
Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo. PLoS One (2011) 0.83
Regulatory myeloid cells in transplantation. Transplantation (2014) 0.83
T Cells: Soldiers and Spies-The Surveillance and Control of Effector T Cells by Regulatory T Cells. Clin J Am Soc Nephrol (2015) 0.82
IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia. Hypertens Pregnancy (2015) 0.81
Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets. Front Immunol (2015) 0.81
Myeloid decidual dendritic cells and immunoregulation of pregnancy: defective responsiveness to Coxiella burnetii and Brucella abortus. Front Cell Infect Microbiol (2014) 0.81
HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia. Front Immunol (2014) 0.81
Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin. Clin Exp Immunol (2013) 0.81
Interferon-α abrogates tolerance induction by human tolerogenic dendritic cells. PLoS One (2011) 0.81
Human placenta-derived adherent cells induce tolerogenic immune responses. Clin Transl Immunology (2014) 0.81
High level of soluble HLA-G in the female genital tract of Beninese commercial sex workers is associated with HIV-1 infection. PLoS One (2011) 0.81
HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia. J Immunol Res (2014) 0.81
Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials. Clin Exp Immunol (2013) 0.81
Some basic aspects of HLA-G biology. J Immunol Res (2014) 0.80
HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche. Front Immunol (2015) 0.80
HLA-G expression levels influence the tolerogenic activity of human DC-10. Haematologica (2015) 0.80
The many faces of human leukocyte antigen-G: relevance to the fate of pregnancy. J Immunol Res (2014) 0.80
HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapy. Mol Med (2015) 0.79
Molecular biomarkers for grass pollen immunotherapy. World J Methodol (2014) 0.79
A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines. J Transl Med (2013) 0.79
Infection and HLA-G molecules in nasal polyposis. J Immunol Res (2014) 0.79
Leukocyte Ig-Like Receptors - A Model for MHC Class I Disease Associations. Front Immunol (2016) 0.79
IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo. J Immunol (2016) 0.78
In vivo induction of regulatory T cells for immune tolerance in hemophilia. Cell Immunol (2015) 0.78
Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis. Mediators Inflamm (2015) 0.78
Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection. Respir Res (2013) 0.78
Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells. Br J Pharmacol (2016) 0.77
Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus. J Clin Immunol (2010) 0.77
Tightly regulated 'all-in-one' lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy. Gene Ther (2015) 0.77
Induction of immunological tolerance to adenoviral vectors by using a novel dendritic cell-based strategy. J Virol (2012) 0.77
Cluster of differentiation 45 activation is crucial in interleukin-10-dependent tumor-associated dendritic cell differentiation. Oncol Lett (2014) 0.76
Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients. Clin Exp Med (2012) 0.76
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy. Oncoimmunology (2016) 0.76
Impaired dendritic cell function in a spontaneous autoimmune polyneuropathy. J Immunol (2015) 0.76
Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer. Mol Ther Methods Clin Dev (2014) 0.76
Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene. Mol Ther (2012) 0.76
High expression of CD11c indicates favorable prognosis in patients with gastric cancer. World J Gastroenterol (2015) 0.75
Effector and suppressor T cells in celiac disease. World J Gastroenterol (2015) 0.75
IL-10: A Multifunctional Cytokine in Viral Infections. J Immunol Res (2017) 0.75
Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin. Immunology (2015) 0.75
Trogocytic intercellular membrane exchanges among hematological tumors. J Hematol Oncol (2015) 0.75
Human monocytes undergo functional re-programming during differentiation to dendritic cell mediated by human extravillous trophoblasts. Sci Rep (2016) 0.75
Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med (2009) 8.20
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood (2005) 6.49
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev (2006) 6.08
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol (2007) 4.55
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol (2006) 4.23
Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med (2002) 3.49
Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity (2011) 3.38
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med (2013) 2.39
Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol (2008) 2.18
Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood (2011) 2.12
Tr1 cells: from discovery to their clinical application. Semin Immunol (2006) 2.05
Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J Clin Invest (2005) 1.92
WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med (2007) 1.77
Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol (2002) 1.76
Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest (2008) 1.73
SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production. Nat Cell Biol (2006) 1.70
Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity (2002) 1.69
In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood (2007) 1.69
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest (2007) 1.67
Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes (2006) 1.65
Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol (2007) 1.61
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. Int Immunol (2008) 1.58
Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci U S A (2002) 1.58
Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells. Diabetes (2008) 1.49
Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol (2007) 1.49
Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes (2009) 1.48
Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes (2006) 1.48
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med (2009) 1.45
Generation of Donor-specific T Regulatory Type 1 Cells From Patients on Dialysis for Cell Therapy After Kidney Transplantation. Transplantation (2015) 1.44
SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood (2005) 1.44
Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J Immunol (2006) 1.44
Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes (2011) 1.39
Nuclear myosin VI enhances RNA polymerase II-dependent transcription. Mol Cell (2006) 1.39
Comment on M. Guillot-Delost et al. (2008;10:834-846): Clinical-grade preparation of human natural regulatory T cells encoding the thymidine kinase suicide gene as a safety gene. J Gene Med (2009) 1.39
In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance. Blood (2009) 1.34
CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev (2005) 1.27
Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells. Haematologica (2011) 1.20
Rapamycin prevents and breaks the anti-CD3-induced tolerance in NOD mice. Diabetes (2009) 1.18
Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes (2013) 1.17
Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol (2014) 1.13
Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection. Eur J Immunol (2005) 1.10
Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation. J Neuroimmunol (2010) 1.08
Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes (2009) 1.08
Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol Ther (2004) 1.06
Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells. J Immunol (2005) 1.06
IL-10-producing T regulatory type 1 cells and oral tolerance. Ann N Y Acad Sci (2004) 1.04
An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells. J Exp Med (2005) 1.04
Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation. Hum Gene Ther (2006) 1.03
Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trial. Transplantation (2014) 1.01
Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunol (2006) 1.00
Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells. Eur J Neurosci (2004) 0.97
Quantitative assessment of the complex dynamics of G1, S, and G2-M checkpoint activities. Cancer Res (2009) 0.94
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells. Mol Ther (2012) 0.93
Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther (2007) 0.93
Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs. J Allergy Clin Immunol (2010) 0.92
Development of lentiviral gene therapy for Wiskott Aldrich syndrome. Expert Opin Biol Ther (2008) 0.91
Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS One (2011) 0.91
Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells. Hum Immunol (2009) 0.90
The role of interleukin 10 in the control of autoimmunity. J Autoimmun (2003) 0.89
Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Clin Immunol (2013) 0.89
Modulation of early inflammatory reactions to promote engraftment and function of transplanted pancreatic islets in autoimmune diabetes. Adv Exp Med Biol (2010) 0.89
HIV-1-derived lentiviral vectors directly activate plasmacytoid dendritic cells, which in turn induce the maturation of myeloid dendritic cells. Hum Gene Ther (2011) 0.88
Abnormalities of the Exocrine Pancreas in Type 1 Diabetes. Curr Diab Rep (2015) 0.87
Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice. Exp Cell Res (2006) 0.87
The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. Eur J Neurosci (2004) 0.86
Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes. Semin Immunol (2011) 0.86
Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells. Neoplasia (2008) 0.85
The puzzling world of murine T regulatory cells. Microbes Infect (2002) 0.84
Reappraisal of in utero stem cell transplantation based on long-term results. Fetal Diagn Ther (2004) 0.84
Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors. Immunol Lett (2013) 0.84
Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy. Front Microbiol (2011) 0.83
Co-graft of allogeneic immune regulatory neural stem cells (NPC) and pancreatic islets mediates tolerance, while inducing NPC-derived tumors in mice. PLoS One (2010) 0.83
T cell-based therapeutic vaccination for spinal cord injury. Prog Brain Res (2002) 0.83
Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID. Immunol Res (2009) 0.83
Relevance of hyperglycemia on the timing of functional loss of allogeneic islet transplants: implication for mouse model. Transplantation (2007) 0.83
The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis. J Immunol (2002) 0.83
Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice. Diabetologia (2015) 0.82
Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review. J Gastroenterol Hepatol (2015) 0.81
Re-establishing immune tolerance in type 1 diabetes via regulatory T cells. Novartis Found Symp (2008) 0.80
Dendritic cells modification during sublingual immunotherapy in children with allergic symptoms to house dust mites. World J Pediatr (2010) 0.80
Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers. Mult Scler (2010) 0.79
The role of cytokines (and not only) in inducing and expanding T regulatory type 1 cells. Transplantation (2004) 0.78
Autoimmune diabetic patients undergoing allogeneic islet transplantation: are we ready for a regulatory T-cell therapy? Immunol Lett (2009) 0.78
Ecoimmunity: immune tolerance by symmetric co-evolution. Evol Dev (2007) 0.78
Regulatory T cells: prospective for clinical application in hematopoietic stem cell transplantation. Curr Opin Hematol (2005) 0.77
Immunological lessons learnt from patients transplanted with fully mismatched stem cells. Immunol Res (2007) 0.77
Plasma levels of soluble MICA and ULBP2 are increased in children allergic to dust mites. J Allergy Clin Immunol (2012) 0.77